Published 2026-06-15
A dense cluster of central bank decisions alongside quarterly options expiration compresses the window for a significant market move while corporate credit health remains under pressure.
At a glance
This weekECB Becomes First Major Central Bank to Raise Interest Rates Since Inflation Resurgence
Model stance62% cash · 18 positions
Track record44% hit rate (n=43)
Recent Events
The European Central Bank became the first major central bank to raise rates since the inflation resurgence, tightening on 11 June a day after a pivotal US CPI release. Fed communication stayed near a whisper—its tone index registered just 15 out of 100—while oil prices steadied even as the US-Iran conflict escalated. On the credit side, high-yield spreads were flat and a broad gauge of corporate health sat at a fragile 40, with 28 companies flagged as in danger, underscoring the strain that also saw Prospect Capital cut its regular dividend by 22% in late May. Separately, Barry Diller’s People made a move to take casino giant MGM private, the FDA ordered Class I recalls for Abiomed and Bolton Medical devices, and the token Stellar surged 29%.
Macro & policy
2026-06-11ECB Becomes First Major Central Bank to Raise Interest Rates Since Inflation Resurgence
2026-06-11Oil prices steady as investors weigh US-Iran war escalation
2026-06-11Fed Communication: 15/100 (LOW)
2026-06-04Fed Communication: 10/100 (LOW)
Credit & corporate
2026-05-27PSEC regular dividend cut: 0.045 → 0.035 (-22.2%)
2026-06-11Buybacks: 7750 active, $65221B TTM
2026-06-11HY OAS Weekly: FLAT → hold cash
2026-06-11Credit survival: avg 40/100, 28 in danger
On the calendar
2026-06-10Consumer Price Index (CPI) release
2026-06-04ECB Governing Council monetary policy meeting
Notable news
2026-06-03Abiomed, Inc.
2026-06-03Bolton Medical Inc.
2026-06-09Barry Diller's People Makes Move To Take Casino Giant MGM Private
2026-05-28stellar: +29.1% (24h) → $0.1926
Upcoming Events
The calendar opens with a dense cluster of monetary policy decisions: the Bank of Japan and the Federal Reserve both conclude meetings on June 17, followed immediately by the Bank of England on June 18. That same day also brings triple witching, which concentrates quarterly options and futures expiration — a combination that compresses the window for a substantial liquidity event and repricing flow into a single session. After that front-loaded stretch, attention turns to a series of top-tier U.S. releases spread across late June and early July, including GDP, the PCE deflator, and the nonfarm payrolls report, before the CPI arrives on July 14.
2026-06-17● Bank of Japan Monetary Policy Meeting (JP)
2026-06-17● FOMC monetary policy decision (US)
2026-06-18● Bank of England MPC monetary policy decision (UK)
2026-06-18● Triple witching (quarterly options & futures expiration) (US)
2026-06-22● PBOC Loan Prime Rate (LPR) fixing (CN)
2026-06-25● Gross Domestic Product (GDP) release (US)
2026-06-25● Personal Income & Outlays (PCE) release (US)
2026-07-02● Employment Situation (Nonfarm Payrolls) release (US)
2026-07-06● SpaceX Nasdaq-100 fast-entry window (US)
2026-07-14● Consumer Price Index (CPI) release (US)
Plus 75 corporate earnings reports scheduled in the window.
Macro Projections
The surface picture is one of calm credit and subdued volatility: high-yield option-adjusted spreads are resting at a tight 2.74–2.78 %, the VIX sits at a steady 19.44, and the MOVE index of Treasury rate swings is falling to 69.36 basis points. Beneath that calm, however, the spread between CCC‑rated and BB‑rated credit is accelerating sharply—from 0.73 toward 2.44—a classic early‑cycle signal that stress is concentrating at the lowest‑quality tier while the broad market stays placid. The macro outlook turns on whether a near‑term geopolitical de‑escalation, with an Iran deal possibly signed within 24 hours and the Strait of Hormuz near‑closure, removes the largest tail and lets the carry structure calm, or whether internal credit deterioration and extreme positioning instead trigger a disorderly unwind even as geopolitics improve. The carry‑unwind framework puts the probability of that disorderly liquidation at 41.4 %, a level that has been stable and elevated across several readings, yet the cross‑asset volatility complex is not confirming the risk: actual G7 FX volatility (a gauge of how much the major currencies are swinging) reads –0.907, still below average though rising from –1.22, and the shape of the VIX futures curve has shifted from backwardation to contango, meaning near‑term insurance is no longer more expensive than deferred protection. The model itself defers to those subdued volatility readings rather than its own elevated‑currency‑volatility tag, but the accelerating CCC/BB spread and the crowded speculative shorts in two‑year Treasuries and the Japanese yen—with dollar‑yen at 160 and Japanese government‑bond stress in the background—argue that the unwind risk is real and underappreciated. In the base case where calm persists, U.S. equities still screen expensive at a cyclically adjusted price‑to‑earnings ratio of 41.4 and an earnings yield of just 2.41 %, against 5.51 % for emerging markets, so the structural case for relative performance favors developed ex‑US and emerging‑market equities. Credit offers little carry reward for that tail risk, and were the unwind to arrive, it would hammer long dollar‑yen, equities, and credit while benefiting long‑duration Treasuries and gold.
Near term ▼●●● expires Jul 14, 2026
The CCC/BB credit-quality reading will exceed 3.0 within 30 calendar days (by July 14, 2026).
The trajectory is accelerating positive: the latest reading is 2.44, up from 1.59 in the prior period, with a trail that shows a sharp upward arc (0.73 → 2.44). HY OAS itself is flat and low, but the intra-credit quality divergence is widening rapidly, a pattern that historically precedes broader credit cracks.
Cyclical ▼●●● expires Sep 12, 2026
The USD/JPY exchange rate will close below 150.00 within 90 calendar days (by September 12, 2026).
The carry-unwind model assigns a 41.4% probability to disorderly unwind, with explanatory tags citing USD/JPY proximate to 160, JGB stress, and extreme carry positioning. COT data confirms an extreme short JPY position by asset managers (reading -2.79), creating a crowded short that could violently reverse.
Secular ▼●●● expires Jun 14, 2027
The MSCI Emerging Markets index will outperform the S&P 500 by at least 10 percentage points (total return, USD) over the next 365 days, through June 13, 2027.
The valuation substrate shows a stark cross-region earnings-yield spread: US equities yield 2.41% (CAPE 41.4) while EM equities yield 5.51%. This is consistent with a secular overvaluation of US assets relative to EM.
If this, then that — the scenario fork
If the US-Iran deal is signed by June 15 and Hormuz reopens, the model estimates a 60% chance that the calm-credit regime holds through Q3, with HY OAS remaining below 3.0%, VIX below 22, and the S&P 500 range-bound; the lead indicator is the CCC/BB reading stabilizing below 2.5. If, however, the Revolutionary Guard blocks the deal or the FOMC/BoJ events trigger a yen appreciation cascade, the disorderly-unwind probability jumps and the regime transitions to a risk-off episode, ~30% probability by late Q3, with HY OAS above 3.0% and VIX >25 as lead indicators.
What would prove this wrong
This framing is wrong if: (i) the Iran deal is signed and Hormuz reopens before June 16, and (ii) the CCC/BB reading retreats below 1.5 by July 1, and (iii) the FOMC communicates a clear 2026 cut timeline, compressing credit spreads further.
Positioning
A calm credit backdrop, with high-yield spreads near 2.80%, anchors the model portfolio. Position weights are scaled directly to the screening-kernel composite score, a measure that blends each name’s expected upside drift with its estimated drawdown probability, so the highest-conviction holdings receive the largest equity allocations. The full holdings and their conviction‑driven sizing are laid out in the model‑portfolio table below.
| Name | Conviction score | Modelled drift |
|---|
| ELA | 4.24 | +4.7% |
| TSM | 4.01 | +4.7% |
| MU | 3.86 | +4.9% |
| IRWD | 3.81 | +4.8% |
| ASRT | 3.79 | +4.5% |
| INOD | 3.77 | +4.6% |
oil supply shock headline cpi → headline CPI ▲ · 86% base rate · n=7 · 60% pricedcommodity production loss → agricultural commodity ▲ · 80% base rate · n=5 · 40% pricedhy oas widen spx drawdown → SPX ▼ · 50% base rate · n=52 · 35% priced
Model Portfolio
The model portfolio maintains a heavy cash reserve, positioning it as dry powder to be phased in as credit and volatility conditions settle. Around that core, structural allocations to inflation-linked Treasuries and gold reflect the financial-repression thesis and a flight-to-quality channel, while a modest quality-equity sleeve leans into the AI capital-expenditure cycle.
Cash 62.0%Inflation-linked 10.0%Gold & metals 5.0%Equity 5.0%
| Name | Weight | Thesis |
|---|
| Cash · 62.0% |
| Money Market | 62.0% | money-market / cash |
| Inflation-linked · 10.0% |
| SCHP | 4.9% | inflation-linked Treasuries |
| VTIP | 2.9% | inflation-linked Treasuries |
| LTPZ | 2.2% | inflation-linked Treasuries |
| Gold & metals · 5.0% |
| IAU | 3.0% | gold / precious-metals |
| GDX | 1.1% | gold / precious-metals |
| WPM | 0.4% | gold / precious-metals |
| FNV | 0.4% | gold / precious-metals |
| SLV | 0.1% | gold / precious-metals |
| Equity · 5.0% |
| QUAL | 2.5% | global quality equity |
| ELA | 0.7% | global quality equity |
| TSM | 0.5% | global quality equity |
| MU | 0.4% | global quality equity |
| IRWD | 0.2% | global quality equity |
| ASRT | 0.2% | global quality equity |
| INOD | 0.2% | global quality equity |
| SNDK | 0.1% | global quality equity |
| HPE | 0.1% | global quality equity |
Position notes
ELA 0.7%
Full research note
Envela buys/sells jewelry and bullion, also provides electronics recycling in the US.
Bull case · Gold and silver prices stay elevated on geopolitical risk and structural inflation, propping up consumer segment margins. The ITAD business scales with AI‑driven data‑center hardware refreshes, adding a recurring, high‑margin revenue stream. With a $442M market cap, the small‑cap geometry offers meaningful upside if execution continues, while the clean insider picture (no selling) suggests alignment.
Bear case · The stock is technically overextended (RSI 72, +107% above 200‑dma) after a 150% six‑month run, leaving it acutely vulnerable to profit‑taking. A sudden drop in gold/silver prices—triggered by an Iran peace deal or hawkish Fed—would directly squeeze margins. Micro‑cap liquidity amplifies losses in any macro risk‑off event (carry unwind, credit stress), and the consumer‑facing segment is sensitive to a recessionary pullback.
Key risks• Precious metals price reversal from geopolitical de‑escalation or real‑rate repricing
• Extreme valuation and technical overbought condition inviting sharp correction
• Macro carry‑trade unwind or geopolitical shock causing indiscriminate small‑cap selling
• Customer concentration and cyclicality in the ITAD business
• Small‑cap illiquidity exacerbating drawdowns in risk‑off environments
TSM 0.5%
Full research note
TSMC is the world's largest dedicated semiconductor foundry, offering advanced manufacturing for a global client base.
Bull case · AI accelerator demand from NVDA, AMD, and hyperscalers drives revenue growth well into the next decade; TSMC's pricing power and margin expansion (66.2% gross margin in Q1 2026) are durable. Analyst revisions over the last 30 days are sharply positive (net +100% up revisions, no downgrades), reflecting a consensus that is still catching up to the AI capex cycle. Decoupling pressures paradoxically benefit TSMC as both US and China build independent chip ecosystems that all depend on leading‑edge manufacturing.
Bear case · A recession or AI capex disappointment would hit TSMC's growth assumptions hard, while the stock is already extended (+27% above 200‑day MA). Geopolitical risk is acute: a Taiwan Strait escalation would disrupt over 90% of advanced chip supply; this risk is not just a tail but an inherent feature of the concentration. US‑China decoupling could force TSMC to lose Chinese market share or require prohibitively expensive geographic diversification.
Key risks• Taiwan Strait military escalation disrupting global semiconductor supply
• AI capex cycle peaking and monetization lag triggering a 2001‑style deep correction
• US‑China decoupling forcing TSMC to choose sides, eroding addressable market
• Insider selling cluster (VP sold $14M) signaling management caution at elevated share prices
• Current the composite macro-signal score safety gate (score 64.3) limiting deployment capacity, leaving any position exposed to macro unwind
MU 0.4%
Full research note
Micron designs and manufactures memory and storage products for various markets.
Bull case · MU is a primary beneficiary of the AI capex cycle, with HBM demand far outstripping supply and a technology lead that locks in hyperscaler customers. Revenue growth is durable, and long-term fundamentals support a higher valuation as memory market consolidation strengthens pricing power. our model's fundamental score is strong, and the AI infrastructure theme remains in an accelerating stage.
Bear case · The stock is extremely overbought after a massive rally (+132.8% above 200MA) and faces significant correction risk. Insider selling has been extreme (>=3.0x 12m avg, 100% S), signaling potential near-term top. Stale macro data (HY OAS and VIX) and the looming AI capex digestion window (peak disappointment risk in mid-2026–2027) raise the probability of a sharp drawdown. Mega-cap geometry limits long-term upside to defensive compounding, not explosive growth.
Key risks• Extreme overbought technicals (RSI and distance from 200MA) invite mean reversion
• Insider selling cluster (extreme selling, >=3.0x 12m avg, 100% S) signals lack of management confidence
• Stale macro data (freshness blocking on HY OAS and VIX) prevents confident deployment
• AI capex disappointment risk — any hyperscaler guide-down could trigger material selloff
• Geopolitical tail risk from Iran/Hormuz and carry unwind scenario (USD/JPY near intervention band)
IRWD 0.2%
Full research note
Ironwood Pharmaceuticals develops GI treatments, primarily LINZESS, with high product concentration.
Bull case · Bulls point to the exceptional cash generation and market dominance of LINZESS, which recently captured ~45% market share and delivered $273 million in Q1 2026 U.S. net sales, driven by improved net pricing and a 5% bump in prescription demand. Furthermore, the FDA's priority review for a pediatric label expansion (PDUFA date of May 24, 2026) and the Q2 2026 initiation of the STARS-2 Phase 3 trial for apraglutide provide near-term catalysts that could diversify revenue and extend the company's growth runway.
Bear case · Bears argue that Ironwood is a "one-trick pony" facing an inevitable patent cliff for Linzess, making its long-term terminal value highly vulnerable to generic erosion. This skepticism is validated by sharply bearish analyst revision momentum (net -100% downward revisions over the last 30 days) and a massive $20.5M insider selling cluster from a Director in March, which explains why the stock plunged 13% despite a Q1 earnings beat as the market aggressively de-risks.
Key risks• Linzess generic erosion timeline uncertainty and the looming patent cliff overhang.
• Pipeline clinical trial failure risk, specifically regarding the STARS-2 Phase 3 trial for apraglutide.
• Heavy insider selling cluster ($20.5M by a Director) signaling a lack of management confidence in near-term upside.
• Sharply negative analyst revision momentum reflecting Wall Street's skepticism of the company's post-Linzess transition.
• Over-reliance on a single commercialized asset (Linzess) for virtually all revenue and cash flow.
ASRT 0.2%
Full research note
The dominant 30-day narrative for Assertio Holdings (ASRT) is entirely consumed by its pending take-private acquisition, marking the end of its run as a standalone entity. Following an initial $18-per-share buyout agreement with Garda Therapeutics in early April 2026, Assertio pivoted on May 13, 2026, agreeing to be acquired by Zydus Worldwide DMCC for $23.50 per share in cash. The stock is currently trading tightly around $23.45, indicating high market confidence that the Zydus deal will close. Concurrently, Assertio sold its non-Rolvedon assets to Cosette Pharmaceuticals for $35 million, effectively liquidating its legacy portfolio.
Bull case · The bull case is now strictly a merger-arbitrage play. Zydus's $23.50 all-cash offer provides a definitive, premium exit for shareholders, rescuing them from a company whose standalone fundamentals were rapidly deteriorating. The extremely tight 5-cent spread to the current $23.45 trading price reflects near-certainty of deal completion, offering a safe, albeit capped, harbor for capital in a volatile tape.
Bear case · The bear case centers entirely on deal-break risk. If the Zydus acquisition faces unexpected regulatory hurdles or financing issues, ASRT shares would likely crater back toward their pre-buyout standalone valuation. The company's Q1 2026 fundamentals were abysmal—revenue plunged to $9.9 million from $26.5 million year-over-year—leaving absolutely no fundamental floor if the merger fails to materialize.
Key risks• Deal-break downside risk if the Zydus acquisition fails to close, exposing shareholders to a broken fundamental story.
• Regulatory or antitrust scrutiny delaying the merger timeline.
• Abysmal standalone fundamentals (Q1 2026 revenue down >60% YoY) offering no safety net.
• Ongoing class-action lawsuits regarding past disclosures of Indocin's generic risks.
INOD 0.2%
Full research note
Innodata is a critical AI data engineering enabler with explosive revenue growth (+54% YoY in Q1 2026) and improving customer diversification, positioning it as a key pick-and-shovel play in the AI adoption cycle.
Bull case · AI-driven data labeling demand accelerates, new large client wins broaden revenue base beyond current concentration, and operating leverage drives margin expansion toward management's 40%+ growth target. Strong FCF generation (FCF margin 38.7% in Q1) provides balance sheet optionality.
Bear case · Heavy insider selling ($35.8M net over 90 days, 100% sell direction) and sharply negative analyst revision momentum (net upgrade rate -100% in 30d) signal internal caution; high valuation (P/E 31.9, EV/EBITDA 20.4) leaves no room for revenue or client-diversification misses. Competitive pressure from well-funded AI data unicorns and potential AI synthetic data disruption loom.
Key risks• Extreme insider selling cluster indicating potential valuation peak and internal skepticism
• Sharply bearish analyst revision momentum contradicting retail euphoria and raising near-term earnings risk
• Customer concentration risk with top customer at 56% of revenue, exposing the business to single-client churn
• Competitive pressure from better-capitalized AI data platforms like Scale AI, which could erode pricing power
• AI disruption risk from synthetic data generation reducing the need for human-in-the-loop data engineering
SNDK 0.1%
Full research note
SanDisk is a NAND flash memory manufacturer facing intense competition and supply chain risks.
Bull case · The stock benefits from powerful momentum and perhaps genuine demand tailwinds in the hardware sector; if the macro backdrop stabilizes and the underlying growth narrative is real, the stock could continue to grind higher. our model's fundamental signal, though modest, provides a floor of support.
Bear case · SNDK is trading +223.9% above its 200‑day moving average, a level that historically precedes sharp mean‑reversion. There is zero visible fundamental catalyst in the brain context, and no analyst coverage or insider conviction to anchor valuation. A macro unwind (Iran, carry trade) could trigger a violent liquidation of momentum names, with SNDK’s extreme extension amplifying downside.
Key risks• Extreme overbought technicals (+223.9% above 200‑dma) invite aggressive profit‑taking
• No fundamental transparency — unknown revenue quality, margins, or competitive moat
• Macro carry‑unwind tail risk (USD/JPY near 160, JGB 10Y approaching 2.85%) could spark a momentum crash
• Large‑cap frame limits upside geometry — 100× is impossible, so the thesis must be defensive, but the stock is acting like a high‑beta speculative name
• Insider activity and analyst coverage are absent, removing traditional conviction anchors
SLV 0.1%
Full research note
The dominant 30-day narrative for the iShares Silver Trust (SLV) centers on a violent macroeconomic tug-of-war. Silver prices have crashed nearly 40% from their early-2026 peaks to approach $60 per ounce, driven by a hawkish Federal Reserve, a surging US dollar, and institutional de-risking. However, the market remains hyper-focused on the underlying structural supply deficit, which is being exacerbated by exploding industrial demand from AI data centers, high-efficiency solar photovoltaics, and electrification, creating a fundamental floor under the metal's valuation.
Bull case · The strongest bullish sentiment anchors on the unprecedented industrial demand wave from AI infrastructure and newer TOPCon solar panels, which are structurally increasing silver intensity per unit. Proponents argue that with mine production severely constrained and consecutive years of global supply deficits, the current macro-driven selloff offers a generational entry point before physical shortages force a violent repricing.
Bear case · Bears point to the immediate macroeconomic reality: a structurally higher US dollar and elevated real yields under a hawkish Fed are crushing the monetary premium of precious metals. This has triggered massive volatility and forced liquidations, with the "safe haven" narrative unwinding rapidly amid potential Middle East de-escalation, leaving silver vulnerable to further downside if industrial demand softens in a recession.
Key risks• Sustained hawkishness from the Federal Reserve driving real yields higher and accelerating ETF redemptions.
• A durable resolution to the Iran-Hormuz conflict draining the geopolitical safe-haven premium from precious metals.
• Technological substitution or "thrifting" in solar panel manufacturing reducing the silver intensity per cell.
• Intense fee competition from lower-cost physical silver ETFs eroding SLV's market share among retail investors.
HPE 0.1%
Full research note
The dominant 30-day narrative for Hewlett Packard Enterprise (HPE) centers on its explosive Q2 2026 earnings report and its rapid emergence as a premier AI infrastructure provider. Following a blowout quarter on June 1 featuring 40% YoY revenue growth and a massive $1.8 billion in new AI system bookings, the stock surged over 30%. The market is hyper-focused on HPE's ability to convert AI demand into tangible revenue, alongside the accelerated integration and cost synergies from its pending $14 billion Juniper Networks acquisition.
Bull case · The strongest bull case revolves around HPE's successful pivot to high-margin networking and AI servers. With cumulative AI systems bookings reaching $16.4 billion and a $5.9 billion backlog entering Q3, HPE is proving it can capture enterprise AI spend at scale. Furthermore, management's upward revision of full-year 2026 guidance, combined with Juniper synergies running ahead of schedule, has triggered a wave of aggressive analyst price target hikes and a sharply bullish revision flow across the Street.
Bear case · The bear case focuses on valuation friction and supply chain vulnerabilities following the stock's nearly 100% year-to-date run. Skeptics warn that severe industry-wide shortages of DRAM and high-bandwidth memory (HBM) are forcing 10-20% server price increases, which could constrain procurement budgets for price-sensitive enterprise customers. Additionally, intense competition from Dell and Supermicro, alongside the risk of an AI capex digestion cycle, leaves little margin for error at current multiples.
Key risks• Severe component shortages (DRAM/HBM) driving up server costs and potentially delaying deployments.
• Valuation overhang and profit-taking risk after a ~45% one-month share price surge.
• Integration execution risks surrounding the $14 billion Juniper Networks acquisition.
• Intense competitive pressure in the AI server market from Dell, Supermicro, and direct-to-cloud alternatives.
Track Record
The model’s four‑week horizon calls over the past 180 days amount to just 43 recommendations — a sample that remains thin and is shared for transparency, not as a statistically meaningful track record. Across those ideas, 44% generated positive alpha, while the mean alpha across the full set came in at -0.7%, despite an average raw return of 7.1%. Every call was logged before the outcome and scored when the horizon closed, reflecting the discipline of evaluating the outlook honestly whether or not the numbers flatter it.
Sample still thin — reported for transparency, not as a settled record.
Macro forecasts: 39 written down with explicit horizons and being tracked; each will be graded against what actually happens as its horizon arrives.
Positions, conflicts & disclosures
DISCLAIMER — NOT INVESTMENT ADVICE (DECISION-LINKED)
This publication provides GENERAL and IMPERSONAL commentary and analysis on a regular schedule. The same content is provided to every subscriber. It is NOT investment advice, is NOT tailored to any individual, and does NOT account for your personal financial situation, objectives, or risk tolerance.
This post reports (1) a rules-based MODEL portfolio — target weights produced by an automated system's published rules, identical for all readers — and (2) DECISION-LINKED activity: how that affiliated automated system actually implemented, or has queued to implement, those rules in accounts belonging to the publication's operator. Model weights are not an account statement; the decision-linked positions and pending orders are REAL and belong to accounts affiliated with this publication's operator. We publish them for transparency on a fixed schedule under our Trading & Publication Policy [link] — not as a recommendation that any security or strategy is suitable for you. Because the publisher and/or operator hold or intend to establish positions in the securities discussed, a conflict of interest exists and our interests may differ from yours.
Nothing here is a recommendation to buy, sell, or hold any security for you specifically. Investing involves risk, including loss of principal. Past performance — model or actual — does not guarantee future results.
[Publisher LLC] is not a registered investment adviser and does not provide individualized investment advice. Consult a licensed professional before making any investment decision. See full disclosures, methodology, and our Trading & Publication Policy at [link].
POSITIONS DISCLOSURE: this is a hypothetical, rules-based model portfolio, not a statement of any individual's actual account; the publisher and/or author may hold positions in one or more of the securities listed.
CONFLICT OF INTEREST: because the publisher and/or author may hold listed securities, a conflict of interest exists and could benefit from price movements; the publisher receives no compensation for featuring any security, and this impersonal model illustration is not personalized investment advice or a solicitation to transact.
MICRO-CAP CAVEAT: some listed names are micro-capitalization securities held at small model weights; micro-caps carry elevated liquidity and volatility risk and are unsuitable for short-term trading — the small weights reflect that risk, and nothing here is a recommendation to scalp or rapidly trade thinly-traded securities.
Intended transactions: the affiliated automated system has open or queued target allocations in the following securities discussed here: ASRT, ELA, FNV, GDX, HPE, IAU, INOD, IRWD, LTPZ, MU, QUAL, SCHP, SLV, SNDK, TSM, VTIP, WPM. These are real pending orders or model target weights in accounts belonging to the publication's operator, disclosed for transparency under our Trading & Publication Policy [link] — not a recommendation, and our interests may differ from yours.
